9-95508249-C-T

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_000264.5(PTCH1):​c.113G>A​(p.Gly38Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000125 in 1,603,018 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G38R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

PTCH1
NM_000264.5 missense

Scores

2
1
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:6

Conservation

PhyloP100: 0.893

Publications

10 publications found
Variant links:
Genes affected
PTCH1 (HGNC:9585): (patched 1) This gene encodes a member of the patched family of proteins and a component of the hedgehog signaling pathway. Hedgehog signaling is important in embryonic development and tumorigenesis. The encoded protein is the receptor for the secreted hedgehog ligands, which include sonic hedgehog, indian hedgehog and desert hedgehog. Following binding by one of the hedgehog ligands, the encoded protein is trafficked away from the primary cilium, relieving inhibition of the G-protein-coupled receptor smoothened, which results in activation of downstream signaling. Mutations of this gene have been associated with basal cell nevus syndrome and holoprosencephaly. [provided by RefSeq, Aug 2017]
PTCH1 Gene-Disease associations (from GenCC):
  • basal cell nevus syndrome 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • holoprosencephaly 7
    Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • nevoid basal cell carcinoma syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
  • holoprosencephaly
    Inheritance: AD Classification: LIMITED Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.23521855).
BP6
Variant 9-95508249-C-T is Benign according to our data. Variant chr9-95508249-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 216367.
BS2
High AC in GnomAd4 at 17 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000264.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTCH1
NM_000264.5
MANE Select
c.113G>Ap.Gly38Glu
missense
Exon 1 of 24NP_000255.2Q13635-1
PTCH1
NM_001083603.3
MANE Plus Clinical
c.199-1650G>A
intron
N/ANP_001077072.1Q13635-2
PTCH1
NM_001354918.2
c.113G>Ap.Gly38Glu
missense
Exon 1 of 23NP_001341847.1A0A1W5YLI7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTCH1
ENST00000331920.11
TSL:5 MANE Select
c.113G>Ap.Gly38Glu
missense
Exon 1 of 24ENSP00000332353.6Q13635-1
PTCH1
ENST00000437951.6
TSL:5 MANE Plus Clinical
c.199-1650G>A
intron
N/AENSP00000389744.2Q13635-2
PTCH1
ENST00000468211.6
TSL:1
c.4-1650G>A
intron
N/AENSP00000449745.1A0A0C4DGJ5

Frequencies

GnomAD3 genomes
AF:
0.000112
AC:
17
AN:
151730
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000387
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.000961
GnomAD2 exomes
AF:
0.0000917
AC:
21
AN:
228974
AF XY:
0.000103
show subpopulations
Gnomad AFR exome
AF:
0.0000738
Gnomad AMR exome
AF:
0.0000600
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000587
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000147
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000126
AC:
183
AN:
1451288
Hom.:
0
Cov.:
34
AF XY:
0.000137
AC XY:
99
AN XY:
721554
show subpopulations
African (AFR)
AF:
0.0000603
AC:
2
AN:
33164
American (AMR)
AF:
0.0000452
AC:
2
AN:
44260
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25978
East Asian (EAS)
AF:
0.0000764
AC:
3
AN:
39254
South Asian (SAS)
AF:
0.000117
AC:
10
AN:
85542
European-Finnish (FIN)
AF:
0.0000403
AC:
2
AN:
49672
Middle Eastern (MID)
AF:
0.00104
AC:
5
AN:
4818
European-Non Finnish (NFE)
AF:
0.000141
AC:
156
AN:
1108808
Other (OTH)
AF:
0.0000502
AC:
3
AN:
59792
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000112
AC:
17
AN:
151730
Hom.:
0
Cov.:
32
AF XY:
0.000121
AC XY:
9
AN XY:
74090
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41408
American (AMR)
AF:
0.00
AC:
0
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10518
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
67772
Other (OTH)
AF:
0.000961
AC:
2
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000367
Hom.:
0
Bravo
AF:
0.000110
ExAC
AF:
0.000126
AC:
15

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
1
-
Craniopharyngioma (1)
-
-
1
Gorlin syndrome (1)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
20
DANN
Benign
0.91
DEOGEN2
Benign
0.18
T
Eigen
Benign
-0.53
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.50
D
LIST_S2
Benign
0.65
T
M_CAP
Pathogenic
0.85
D
MetaRNN
Benign
0.24
T
MetaSVM
Uncertain
-0.27
T
MutationAssessor
Benign
0.69
N
PhyloP100
0.89
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
0.44
N
REVEL
Benign
0.16
Sift
Benign
0.38
T
Sift4G
Benign
0.19
T
Polyphen
0.0010
B
Vest4
0.18
MutPred
0.23
Loss of loop (P = 0.0073)
MVP
0.19
MPC
1.6
ClinPred
0.035
T
GERP RS
3.7
PromoterAI
0.0088
Neutral
Varity_R
0.043
gMVP
0.31
Mutation Taster
=34/66
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143494325; hg19: chr9-98270531; COSMIC: COSV59494982; API